Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
The Veterinary Record
|
May 6, 2018
Frank Lloyd-Griffiths
Mark Furber, Caroline Bower
Organic & Biomolecular Chemistry
|
July 16, 2004
Synthesis of alpha-iminoimidates by palladium catalysed double isonitrile insertion
Richard J Whitby, C Gustaf Saluste, Mark Furber
Purinergic Signalling
|
November 25, 2010
The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro
Ankita Agrawal, Katherine A Buckley, Keith Bowers, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
August 30, 2012
Organocatalytic enantioselective one-pot four-component ugi-type multicomponent reaction for the synthesis of epoxy-tetrahydropyrrolo[3,4-b]pyridin-5-ones
Yingpeng Su, Marinus J Bouma, Lilian Alcaraz, et al.
Journal of Medicinal Chemistry
|
February 5, 2009
Antagonists of the P2X(7) receptor. From lead identification to drug development
Simon D Guile, Lilian Alcaraz, Timothy N Birkinshaw, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists
Christopher A Luckhurst, Marianne Ratcliffe, Linda Stein, et al.
Chemmedchem
|
April 27, 2011
The discovery of MMP7 inhibitors exploiting a novel selectivity trigger
Karl Edman, Mark Furber, Paul Hemsley, et al.
Journal of Cell Science
|
March 7, 2019
NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation
Paulina Kucharzewska, Chrissta X Maracle, Kim C M Jeucken, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 25, 2010
Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists
Christopher A Luckhurst, Linda A Stein, Mark Furber, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 13, 2012
Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part I
Mark Furber, Lilian Alcaraz, Christopher Luckhurst, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
The Veterinary Record
|
May 6, 2018
Frank Lloyd-Griffiths
Mark Furber, Caroline Bower
Organic & Biomolecular Chemistry
|
July 16, 2004
Synthesis of alpha-iminoimidates by palladium catalysed double isonitrile insertion
Richard J Whitby, C Gustaf Saluste, Mark Furber
Purinergic Signalling
|
November 25, 2010
The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro
Ankita Agrawal, Katherine A Buckley, Keith Bowers, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
August 30, 2012
Organocatalytic enantioselective one-pot four-component ugi-type multicomponent reaction for the synthesis of epoxy-tetrahydropyrrolo[3,4-b]pyridin-5-ones
Yingpeng Su, Marinus J Bouma, Lilian Alcaraz, et al.
Journal of Medicinal Chemistry
|
February 5, 2009
Antagonists of the P2X(7) receptor. From lead identification to drug development
Simon D Guile, Lilian Alcaraz, Timothy N Birkinshaw, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists
Christopher A Luckhurst, Marianne Ratcliffe, Linda Stein, et al.
Chemmedchem
|
April 27, 2011
The discovery of MMP7 inhibitors exploiting a novel selectivity trigger
Karl Edman, Mark Furber, Paul Hemsley, et al.
Journal of Cell Science
|
March 7, 2019
NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation
Paulina Kucharzewska, Chrissta X Maracle, Kim C M Jeucken, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 25, 2010
Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists
Christopher A Luckhurst, Linda A Stein, Mark Furber, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 13, 2012
Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part I
Mark Furber, Lilian Alcaraz, Christopher Luckhurst, et al.
Page
of 2